The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy
Abstract Mitochondrial transplantation (MTx) offers a promising therapeutic approach to mitigate mitochondrial dysfunction in conditions such as ischemia–reperfusion (IR) injury. The quality and viability of donor mitochondria are critical to MTx success, necessitating the optimization of isolation...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-86760-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832571763454640128 |
---|---|
author | Ryosuke Takegawa Kei Hayashida Atsushi Murao Yusuke Endo Cyrus E. Kuschner Jacob Kazmi Eriko Nakamura Ping Wang Lance B. Becker |
author_facet | Ryosuke Takegawa Kei Hayashida Atsushi Murao Yusuke Endo Cyrus E. Kuschner Jacob Kazmi Eriko Nakamura Ping Wang Lance B. Becker |
author_sort | Ryosuke Takegawa |
collection | DOAJ |
description | Abstract Mitochondrial transplantation (MTx) offers a promising therapeutic approach to mitigate mitochondrial dysfunction in conditions such as ischemia–reperfusion (IR) injury. The quality and viability of donor mitochondria are critical to MTx success, necessitating the optimization of isolation protocols. This study aimed to assess a rapid mitochondrial isolation method, examine the relationship between mitochondrial size and membrane potential, and evaluate the potential benefits of Poloxamer 188 (P-188) in improving mitochondrial quality during the isolation process. Mitochondria were isolated from pectoral muscle biopsies of adult male Sprague–Dawley rats using an automated homogenizer. MitoTracker Deep Red (MTDR) staining and flow cytometry were used to assess mitochondrial purity, while the JC-1 assay evaluated membrane potential. Mitochondrial size groups were compared for membrane potential differences. Homogenization frequency and P-188 supplementation (1 mM) were assessed for their effects on mitochondrial membrane potential and particle size, and particle counts. The rapid isolation method yielded mitochondria that retained sufficient membrane potential to be effectively inhibited by carbonyl cyanide 3-chlorophenylhydrazone (CCCP), a disruptor of mitochondrial membrane potential. Larger mitochondria exhibited significantly higher JC-1 ratios, indicating greater membrane potential. Excessive homogenization (10 cycles) reduced membrane potential compared to 3 cycles homogenization (P = 0.026). P-188 significantly increased the JC-1 ratio from 10.26 ± 2.57 to 33.78 ± 17.78 (P = 0.023). Particle size and count analysis revealed that 10 cycles homogenization significantly increased particle count compared to 3 cycles homogenization (P = 0.0001), but was associated with smaller particle sizes (P = 0.0031). The rapid mitochondrial isolation method produced viable mitochondria, with larger mitochondria exhibiting superior membrane potential. Reducing homogenization frequency and incorporating P-188 improved mitochondrial quality and preserved particle size. These strategies offer promising strategies for optimizing MTx protocols. Further refinement of these techniques is necessary for their clinical application in MTx therapy. |
format | Article |
id | doaj-art-f39c713b17b8486cb705f81804980b73 |
institution | Kabale University |
issn | 2045-2322 |
language | English |
publishDate | 2025-01-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj-art-f39c713b17b8486cb705f81804980b732025-02-02T12:20:45ZengNature PortfolioScientific Reports2045-23222025-01-011511910.1038/s41598-025-86760-yThe role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapyRyosuke Takegawa0Kei Hayashida1Atsushi Murao2Yusuke Endo3Cyrus E. Kuschner4Jacob Kazmi5Eriko Nakamura6Ping Wang7Lance B. Becker8Laboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthCenter for Immunology and Inflammation, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthCenter for Immunology and Inflammation, Feinstein Institutes for Medical Research, Northwell HealthLaboratory for Critical Care Physiology, Feinstein Institutes for Medical Research, Northwell HealthAbstract Mitochondrial transplantation (MTx) offers a promising therapeutic approach to mitigate mitochondrial dysfunction in conditions such as ischemia–reperfusion (IR) injury. The quality and viability of donor mitochondria are critical to MTx success, necessitating the optimization of isolation protocols. This study aimed to assess a rapid mitochondrial isolation method, examine the relationship between mitochondrial size and membrane potential, and evaluate the potential benefits of Poloxamer 188 (P-188) in improving mitochondrial quality during the isolation process. Mitochondria were isolated from pectoral muscle biopsies of adult male Sprague–Dawley rats using an automated homogenizer. MitoTracker Deep Red (MTDR) staining and flow cytometry were used to assess mitochondrial purity, while the JC-1 assay evaluated membrane potential. Mitochondrial size groups were compared for membrane potential differences. Homogenization frequency and P-188 supplementation (1 mM) were assessed for their effects on mitochondrial membrane potential and particle size, and particle counts. The rapid isolation method yielded mitochondria that retained sufficient membrane potential to be effectively inhibited by carbonyl cyanide 3-chlorophenylhydrazone (CCCP), a disruptor of mitochondrial membrane potential. Larger mitochondria exhibited significantly higher JC-1 ratios, indicating greater membrane potential. Excessive homogenization (10 cycles) reduced membrane potential compared to 3 cycles homogenization (P = 0.026). P-188 significantly increased the JC-1 ratio from 10.26 ± 2.57 to 33.78 ± 17.78 (P = 0.023). Particle size and count analysis revealed that 10 cycles homogenization significantly increased particle count compared to 3 cycles homogenization (P = 0.0001), but was associated with smaller particle sizes (P = 0.0031). The rapid mitochondrial isolation method produced viable mitochondria, with larger mitochondria exhibiting superior membrane potential. Reducing homogenization frequency and incorporating P-188 improved mitochondrial quality and preserved particle size. These strategies offer promising strategies for optimizing MTx protocols. Further refinement of these techniques is necessary for their clinical application in MTx therapy.https://doi.org/10.1038/s41598-025-86760-yMitochondrial transplantationMitochondrial isolationPoloxamer 188JC-1Mitochondrial membrane potential |
spellingShingle | Ryosuke Takegawa Kei Hayashida Atsushi Murao Yusuke Endo Cyrus E. Kuschner Jacob Kazmi Eriko Nakamura Ping Wang Lance B. Becker The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy Scientific Reports Mitochondrial transplantation Mitochondrial isolation Poloxamer 188 JC-1 Mitochondrial membrane potential |
title | The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy |
title_full | The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy |
title_fullStr | The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy |
title_full_unstemmed | The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy |
title_short | The role of homogenization cycles and Poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy |
title_sort | role of homogenization cycles and poloxamer 188 on the quality of mitochondria isolated for use in mitochondrial transplantation therapy |
topic | Mitochondrial transplantation Mitochondrial isolation Poloxamer 188 JC-1 Mitochondrial membrane potential |
url | https://doi.org/10.1038/s41598-025-86760-y |
work_keys_str_mv | AT ryosuketakegawa theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT keihayashida theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT atsushimurao theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT yusukeendo theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT cyrusekuschner theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT jacobkazmi theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT erikonakamura theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT pingwang theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT lancebbecker theroleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT ryosuketakegawa roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT keihayashida roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT atsushimurao roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT yusukeendo roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT cyrusekuschner roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT jacobkazmi roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT erikonakamura roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT pingwang roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy AT lancebbecker roleofhomogenizationcyclesandpoloxamer188onthequalityofmitochondriaisolatedforuseinmitochondrialtransplantationtherapy |